Necrotizing Soft Tissue Infections Study

About this Trial

Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections (ACCUTE)

• Status: Enrolling now
• Location: Miami Valley Hospital
• Study type: Interventional
• Ages eligible for study: 18 and older
• Genders eligible for study: Both
• Principal Investigator: Akpofure Peter Ekeh, M.D.
• For more information about this study, visit ClinicalTrials.gov: NCT02469857

If you would like information about participating in this study, contact:

Contact us

Linda Clark, MSN, RN
(937) 208-2913
lclark@premierhealth.com